Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tryptophan MRI in People With Schizophrenia and Healthy Controls

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02067975
Recruitment Status : Completed
First Posted : February 20, 2014
Last Update Posted : February 7, 2020
Sponsor:
Collaborators:
Mitsubishi Tanabe Pharma Corporation
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
Robert Buchanan, University of Maryland, College Park

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : December 2019
Actual Study Completion Date : December 2019
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 April 28, 2021
May 19, 2021